Association between arterial stiffness and serum L-octanoylcarnitine and lactosylceramide in overweight middle-aged subjects: 3-Year follow-up study

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Kim, Minjoo ^a   Jung, Saem ^a   Lee, Sang Hyun ^b   Lee, Jong Ho ^a  

^a Yonsei University   (South Korea)

^b National Health Insurance Corporation   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CARNITINE DERIVATIVE; DECANOYLCARNITINE; FATTY ACID; GLUCOSE; INSULIN; LACTOSYLCERAMIDE; LEUCINE; LEVO OCTANOYLCARNITINE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; CARNITINE; CDW17 ANTIGEN; LEUKOCYTE ANTIGEN; OCTANOYLCARNITINE;

ABDOMINAL OBESITY; ADULT; ARTERIAL STIFFNESS; ARTICLE; BLOOD LEVEL; BODY MASS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MIDDLE AGED; OBESITY; PULSE WAVE; SYSTOLIC BLOOD PRESSURE; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; WAIST CIRCUMFERENCE; ANALOGS AND DERIVATIVES; BLOOD; BLOOD PRESSURE; CASE CONTROL STUDY; COMPLICATION;

ADULT; ANTIGENS, CD; BLOOD PRESSURE; BODY MASS INDEX; CARNITINE; CASE-CONTROL STUDIES; HUMANS; LACTOSYLCERAMIDES; LEUCINE; MIDDLE AGED; OVERWEIGHT; VASCULAR STIFFNESS;

EID: 84925047575     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119519     Document Type: Article

References (49)

1. Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013; 309: 71-82. doi: 10.1001/jama.2012.113905 PMID: 23280227
2. Borrell LN, Samuel L. Body Mass Index Categories and Mortality Risk in US Adults: The Effect of Overweight and Obesity on Advancing Death. Am J Public Health. 2014; 104: 512-519. doi: 10.2105/AJPH.2013.301597 PMID: 24432921
3. McDonough C, Dunkley AJ, Aujla N, Morris D, Davies MJ, Khunti K. The association between body mass index and health-related quality of life: influence of ethnicity on this relationship. Diabetes Obes Metab, 2013; 15: 342-348. doi: 10.1111/dom.12033 PMID: 23137289
4. Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation. 2006; 113: 657-663. PMID: 16461838
5. Tsuchikura S, Shoji T, Kimoto E, Shinohara K, Hatsuda S, Koyama H, et al. Central versus peripheral arterial stiffness in association with coronary, cerebral and peripheral arterial disease. Atherosclerosis. 2010; 211: 480-485. doi: 10.1016/j.atherosclerosis.2010.03.037 PMID: 20430390
6. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010; 55: 1318-1327. doi: 10.1016/j.jacc.2009.10.061 PMID: 20338492
7. Kangas P, Tikkakoski AJ, Tahvanainen AM, Leskinen MH, Viitala JM, Kähönen M, et al. Metabolic syndrome may be associated with increased arterial stiffness even in the absence of hypertension: a study in 84 cases and 82 controls. Metabolism. 2013; 62: 1114-1122. doi: 10.1016/j.metabol.2013.02.009 PMID: 23557592
8. Kolade OO, O'Moore-Sullivan TM, Stowasser M, Coombes JS, Fassett RG, Marwick TH, et al. Arterial stiffness, central blood pressure and body size in health and disease. Int J Obes. 2012; 36: 93-99. doi: 10.1038/ijo.2011.79 PMID: 21487397
9. Sutton-Tyrrell K, Newman A, Simonsick EM, Havlik R, Pahor M, Lakatta E, et al. Aortic stiffness is associated with visceral adiposity in older adults enrolled in the study of health, aging, and body composition. Hypertension. 2001; 38: 429-433. PMID: 11566917
10. Wildman RP, Mackey RH, Bostom A, Thompson T, Sutton-Tyrrell K. Measures of obesity are associated with vascular stiffness in young and older adults. Hypertension. 2003; 42: 468-473. PMID: 12953016
11. Kim OY, Paik JK, Lee JY, Lee SH, Lee JH. Follow-ups of metabolic, inflammatory and oxidative stress markers, and brachial-ankle pulse wave velocity in middle-aged subjects without metabolic syndrome. Clin Exp Hypertens. 2013; 35: 382-388. doi: 10.3109/10641963.2012.739232 PMID: 23148723
12. Choo J, Shin C, Barinas-Mitchell E, Masaki K, Willcox BJ, Seto TB, et al. Regional pulse wave velocities and their cardiovascular risk factors among healthy middle-aged men: a cross-sectional population-based study. BMC Cardiovasc Disord. 2014; 14: 5. doi: 10.1186/1471-2261-14-5 PMID: 24410766
13. Li M, Wang B, Zhang M, Rantalainen M, Wang S, Zhou H, et al. Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci U.S.A. 2008; 105: 2117-2122. doi: 10.1073/pnas. 0712038105 PMID: 18252821
14. Yang L, Xiong A, He Y, Wang Z, Wang C, Wang Z, et al. Bile acids metabonomic study on the CCl4-and α-naphthylisothiocyanate-induced animal models: Quantitative analysisof 22 bile acids by ultraperformance liquid chromatography-mass spectrometry. Chem Res Toxicol. 2008; 21: 2280-2288. doi: 10.1021/tx800225q PMID: 19053324
15. Ahn Y, Park SJ, Kwack HK, Kim MK, Ko KP, Kim SS. Rice-eating pattern and the risk of metabolic syndrome especially waist circumference in Korean Genome and Epidemiology Study (KoGES). BMC Public Health. 2013; 13: 61. doi: 10.1186/1471-2458-13-61 PMID: 23339671
16. Shim YJ, Paik HY. Reanalysis of 2007 Korean National Health and Nutrition Examination Survey (2007 KNHANES) results by CAN-Pro 3.0 Nutrient Database. Korean J Nutr. 2009; 42: 577-595.
17. Choi HJ, Song JM, Kim EK. Assessment of daily steps, activity coefficient, body composition, resting energy expenditure and daily energy expenditure in female university students. J Korean Diet Assoc. 2005; 11: 159-169.
18. Tomiyama H, Yamashina A. Non-invasive vascular function tests: their pathophysiological background and clinical application. Circ J. 2010; 74: 24-33. PMID: 19920359
19. Tsuchikura S, Shoji T, Kimoto E, Shinohara K, Hatsuda S, Koyama H, et al. Brachial-ankle pulse wave velocity as an index of central arterial stiffness. J Atheroscler Thromb. 2010; 17: 658-665. PMID: 20467192
20. Stephens FB, Constantin-Teodosiu D, Greenhaff PL. New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle. J Physiol. 2007; 581: 431-444. PMID: 17331998
21. Ramos-Roman MA, Sweetman L, Valdez MJ, Parks EJ. Postprandial changes in plasma acylcarnitine concentrations as markers of fatty acid flux in overweight and obesity. Metabolism. 2012; 61: 202-212. doi: 10.1016/j.metabol.2011.06.008 PMID: 21820684
22. Mai M, Tönjes A, Kovacs P, Stumvoll M, Fiedler GM, Leichtle AB. Serum levels of acylcarnitines are altered in prediabetic conditions. PLoS One. 2013; 8: e82459. doi: 10.1371/journal.pone.0082459 PMID: 24358186
23. Mihalik SJ, Michaliszyn SF, de las Heras J, Bacha F, Lee S, Chace DH, et al. Metabolomic profiling of fatty acid and amino acid metabolism in youth with obesity and type 2 diabetes: evidence for enhanced mitochondrial oxidation. Diabetes Care. 2012; 35: 605-611. doi: 10.2337/DC11-1577 PMID: 22266733
24. Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009; 9: 311-326. doi: 10.1016/j.cmet.2009.02.002 PMID: 19356713
25. Kim JY, Park JY, Kim OY, Ham BM, Kim HJ, Kwon DY, et al. Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS). J Proteome Res. 2010; 9: 4368-4375. doi: 10.1021/pr100101p PMID: 20560578
26. Goodpaster BH, Kelley DE. Skeletal muscle triglyceride: marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus? Curr Diab Rep. 2002; 2: 216-222. PMID: 12643176
27. Muoio DM, Newgard CB. Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol. 2008; 9: 193-205. doi: 10.1038/nrm2327 PMID: 18200017
28. Seiler SE, Martin OJ, Noland RC, Slentz DH, DeBalsi KL, Ilkayeva OR, et al. Obesity and lipid stress inhibit carnitine acetyltransferase activity. J Lipid Res. 2014; 55: 635-644. doi: 10.1194/jlr.M043448 PMID: 24395925
29. Boden G, Shulman GI. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest. 2002; 32 (Suppl 3): 14-23. PMID: 12028371
30. Hoppel CL, Genuth SM. Carnitine metabolism in normal-weight and obese human subjects during fasting. Am J Physiol. 1980; 238: E409-E415. PMID: 7377339
31. Redman LM, Huffman KM, Landerman LR, Pieper CF, Bain JR, Muehlbauer MJ, et al. Effect of caloric restriction with and without exercise on metabolic intermediates in nonobese men and women. J Clin Endocrinol Metab. 2011; 96: E312-E321. doi: 10.1210/jc.2010-1971 PMID: 21123443
32. Mihalik SJ, Goodpaster BH, Kelley DE, Chace DH, Vockley J, Toledo FG, et al. Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity. Obesity. 2010; 18: 1695-1700. doi: 10.1038/oby.2009.510 PMID: 20111019
33. Zhao X, Peter A, Fritsche J, Elcnerova M, Fritsche A, Häring HU, et al. Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at? Am J Physiol Endocrinol Metab. 2009; 296: E384-E393. doi: 10.1152/ajpendo.90748.2008 PMID: 19066319
34. Adams SH, Hoppel CL, Lok KH, Zhao L, Wong SW, Minkler PE, et al. Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women. J Nutr. 2009; 139: 1073-1081. doi: 10.3945/jn.108.103754 PMID: 19369366
35. Krssak M, Falk Petersen K, Dresner A, DiPietro L, Vogel SM, Rothman DL, et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia. 1999; 42: 113-116. PMID: 10027589
36. Lackey DE, Lynch CJ, Olson KC, Mostaedi R, Ali M, Smith WH, et al. Regulation of adipose branched-chain amino acid catabolism enzyme expression and cross-adipose amino acid flux in human obesity. Am J Physiol Endocrinol Metab. 2013; 304: E1175-E1187. doi: 10.1152/ajpendo.00630.2012 PMID: 23512805
37. Herman MA, She P, Peroni OD, Lynch CJ, Kahn BB. Adipose tissue branched chain amino acid (BCAA) metabolism modulates circulating BCAA levels. J Biol Chem. 2010; 285: 11348-11356. doi: 10.1074/jbc.M109.075184 PMID: 20093359
38. Salomaa V, Riley W, Kark JD, Nardo C, Folsom AR. Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes. The ARIC Study. Atherosclerosis Risk in Communities Study. Circulation. 1995; 91: 1432-1443. PMID: 7867184
39. Sutton-Tyrrell K, Newman A, Simonsick EM, Havlik R, Pahor M, Lakatta E, et al. Aortic stiffness is associated with visceral adiposity in older adults enrolled in the study of health, aging, and body composition. Hypertension. 2001; 38: 429-433. PMID: 11566917
40. Draznin B. Molecular mechanisms of insulin resistance: serine phosphorylation of insulin receptor substrate-1 and increased expression of p85alpha: the two sides of a coin. Diabetes. 2006; 55: 2392-2397. PMID: 16873706
41. Madonna R, De Caterina R. Atherogenesis and diabetes: focus on insulin resistance and hyperinsulinemia. Rev Esp Cardiol. 2012; 65: 309-313. doi: 10.1016/j.recesp.2011.11.010 PMID: 22357362
42. Adams SH. Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state. Adv Nutr. 2011; 2: 445-456. doi: 10.3945/an.111.000737 PMID: 22332087
43. De Guzman JM, Ku G, Fahey R, Youm YH, Kass I, Ingram DK, et al. Chronic caloric restriction partially protects against age-related alteration in serum metabolome. Age. 2013; 35: 1091-104. doi: 10.1007/s11357-012-9430-x PMID: 22661299
44. Rajesh M, Kolmakova A, Chatterjee S. Novel role of lactosylceramide in vascular endothelial growth factor-mediated angiogenesis in human endothelial cells. Circ Res. 2005; 97: 796-804. PMID: 16151023
45. Gong N, Wei H, Chowdhury SH, Chatterjee S. Lactosylceramide recruits PKCalpha/epsilon and phospholipase A2 to stimulate PECAM-1 expression in human monocytes and adhesion to endothelial cells. Proc Natl Acad Sci U S A. 2004; 101: 6490-6495. PMID: 15084746
46. Chakraborti S. Phospholipase A(2) isoforms: a perspective. Cell Signal. 2003; 15: 637-665. PMID: 12742226
47. Steven EK, Rebecca LH, Kristina MU. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006; 444: 840-846. PMID: 17167471
48. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006; 116: 1793-1801. PMID: 16823477
49. Williams R, Lenz EM, Wilson AJ, Granger J, Wilson ID, Major H, et al. A multi-analytical platform approach to the metabonomic analysis of plasma from normal and Zucker (fa/fa) obese rats. Mol Biosyst. 2006; 2: 174-183. PMID: 16880935